Edwards Lifesciences Corp

EW 10-Q · Q3 2025
API behind this page

EW Q3 2025 request

Playground key active
Request URL /api/financials?ticker=EW&year=2025&quarter=3
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q3 2025 Q3 2024 YoY
Revenue 1,553.1 1,354.4 +14.7%
Show Product Lines breakouts
Surgical Structural Heart 258 240 +7.5%
Transcatheter Aortic Valve Replacement 1,149.9 1,023.3 +12.4%
Transcatheter Mitral and Tricuspid Therapies 145.2 91.1 +59.4%
Show Business Segments breakouts
Europe · Operating Segments 387.9 319.8 +21.3%
Japan · Operating Segments 90.1 81.4 +10.7%
Rest of World · Operating Segments 167.6 148.6 +12.8%
United States · Operating Segments 907.5 804.6 +12.8%
Show Consolidation Items breakouts
Operating Segments 1,553.1 1,354.4 +14.7%
Cost of Revenue 345.2 262.9 +31.3%
Show Business Segments breakouts
Europe · Operating Segments 82.4 72.7 +13.3%
Japan · Operating Segments 13.3 11.7 +13.7%
Rest of World · Operating Segments 40.8 41 -0.5%
United States · Operating Segments 167.1 126.6 +32.0%
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income 8 -17 +147.1%
Show Consolidation Items breakouts
Operating Segments 303.6 252 +20.5%
Gross Profit 1,207.9 1,091.5 +10.7%
Selling, General & Administrative 514.6 421.4 +22.1%
Show Business Segments breakouts
Europe · Operating Segments 70 65 +7.7%
Japan · Operating Segments 17.9 17.7 +1.1%
Rest of World · Operating Segments 49.5 43.1 +14.8%
United States · Operating Segments 140.2 126.2 +11.1%
Show Consolidation Items breakouts
Operating Segments 277.6 252 +10.2%
Research & Development 280.7 253.4 +10.8%
Litigation Settlement Expense 90.4 10.8 +737.0%
Show Consolidation Items breakouts
Material Reconciling Items 90.4 10.8 +737.0%
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 -12.5 — —
Show Consolidation Items breakouts
Material Reconciling Items -12.5 — —
Restructuring Charges 0.1 32.9 -99.7%
Impairment Of Intangible Assets Finitelived 40 — —
Show Consolidation Items breakouts
Material Reconciling Items 40 — —
Other Operating Income Expense Net -12.5 22.4 -155.8%
Operating Income 307.1 350.6 -12.4%
Show Consolidation Items breakouts
Operating Segments 947.9 850.1 +11.5%
Interest Income Expense Nonoperating Net -38.6 -24.3 -58.8%
Show Equity Components breakouts
Accumulated Net Unrealized Investment Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income -21.9 -0.8 -2637.5%
Other Non-Operating Income (Expense) -2.7 -27.9 +90.3%
Show Equity Components breakouts
Accumulated Translation Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income -1.6 -1.6 0.0%
Income Before Taxes 348.4 402.8 -13.5%
Income Tax Expense (Benefit) 56.1 40.7 +37.8%
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income -2 4.2 -147.6%
Accumulated Net Unrealized Investment Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income 5.4 0.2 +2600.0%
Accumulated Translation Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income 0.4 0.5 -20.0%
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest 292.3 362.1 -19.3%
Income Loss From Discontinued Operations Net Of Tax -2 2,707.3 -100.1%
Net Income 290.3 3,069.4 -90.5%
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income -6 12.8 -146.9%
Accumulated Net Unrealized Investment Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income 16.5 0.6 +2650.0%
Accumulated Translation Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income 1.2 1.1 +9.1%
Noncontrolling Interest -0.8 -1.4 +42.9%
Parent 291.1 3,070.8 -90.5%
Retained Earnings 291.1 3,070.8 -90.5%
Net Income Loss Attributable To Noncontrolling Interest -0.8 -1.4 +42.9%
Net Income 291.1 3,070.8 -90.5%
Income Loss From Continuing Operations Per Basic Share 0.5 0.61 -18.0%
EPS (Basic) 0.5 5.14 -90.3%
Income Loss From Continuing Operations Per Diluted Share 0.5 0.61 -18.0%
EPS (Diluted) 0.5 5.13 -90.3%
Wtd Avg Shares (Basic) 584.7 597.2 -2.1%
Wtd Avg Shares (Diluted) 585.7 598.1 -2.1%
Total Costs & Expenses (Q) — — —
Show Consolidation Items breakouts
Corporate Non Segment -510.5 -468.7 -8.9%
Non-Operating Income (Expense) 41.3 52.2 -20.9%
Comprehensive Income 304.8 3,038.5 -90.0%
Other Comprehensive Income 13.7 -32.3 +142.4%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 13.7 -32.3 +142.4%
Parent 13.7 -32.3 +142.4%
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments (Q) — — —
Show Business Segments breakouts
Europe · Operating Segments 206.6 177.3 +16.5%
Japan · Operating Segments 59.8 54.4 +9.9%
Rest of World · Operating Segments 82 67.2 +22.0%
United States · Operating Segments 599.5 551.2 +8.8%
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income -8 17 -147.1%
Show Consolidation Items breakouts
Operating Segments 947.9 850.1 +11.5%
Interest Income Expense Net 38.6 24.3 +58.8%
Foreign Currency Transaction Gain Loss Before Tax (Q) — — —
Show Consolidation Items breakouts
Material Reconciling Items -12.3 12.9 -195.3%

Balance Sheet

Balance Sheet
Metric Q3 2025 Q3 2024 YoY
Current Assets
Cash & Cash Equivalents 2,685.6 3,676.4 -27.0%
Show Statement Operating Activities Segment breakouts
Segment Continuing Operations 2,685.6 3,676.4 -27.0%
Segment Discontinued Operations 7.5 2.9 +158.6%
Short-Term Investments 1,156.4 769.7 +50.2%
Accounts Receivable 693.3 716 -3.2%
Other Receivables Net Current 199.5 95.5 +108.9%
Inventory 1,140.9 1,104.2 +3.3%
Prepaid Expense Current 125.2 114.9 +9.0%
Other Assets Current 323.4 231 +40.0%
Assets Of Disposal Group Including Discontinued Operation Current 34.6 — —
Show Disposal Group Classification breakouts
Discontinued Operations Disposed Of By Sale · Critical Care 34.6 — —
Total Current Assets 6,358.9 6,727.7 -5.5%
Non-Current Assets
Long Term Investments 274.7 319.6 -14.0%
Property, Plant & Equipment 1,743.3 1,675.7 +4.0%
Operating Lease Right-of-Use Assets 96.5 104.4 -7.6%
Goodwill 1,768.5 — —
Deferred Tax Assets 1,099.9 888.4 +23.8%
Other Non-Current Assets 784.8 683.5 +14.8%
Disposal Group Including Discontinued Operation Assets Noncurrent 14.8 — —
Show Disposal Group Classification breakouts
Discontinued Operations Disposed Of By Sale · Critical Care 14.8 — —
Total Assets 13,272.2 — —
Other Assets
Intangible Assets Net Excluding Goodwill 1,130.8 956.1 +18.3%
Current Liabilities
Accounts Payable 165 172.8 -4.5%
Accrued And Other Liabilities Current 1,393.9 1,745.3 -20.1%
Operating Lease Liability Current 26.8 24.2 +10.7%
Liabilities Of Disposal Group Including Discontinued Operation Current 2.3 — —
Show Disposal Group Classification breakouts
Discontinued Operations Disposed Of By Sale · Critical Care 2.3 — —
Total Current Liabilities 1,588 1,944.1 -18.3%
Non-Current Liabilities
Long-Term Debt 598.2 597.5 +0.1%
Operating Lease Liabilities 75.3 85 -11.4%
Liability For Uncertain Tax Positions Noncurrent 442.9 345.6 +28.2%
Other Non-Current Liabilities 362.6 322.6 +12.4%
Liabilities Of Disposal Group Including Discontinued Operation Noncurrent 0.2 — —
Show Disposal Group Classification breakouts
Discontinued Operations Disposed Of By Sale · Critical Care 0.2 — —
Total Liabilities 3,067.2 — —
Stockholders' Equity
Common Stock 658.2 654.3 +0.6%
Additional Paid In Capital Common Stock 2,697.4 2,452.1 +10.0%
Retained Earnings 14,149.3 12,781.4 +10.7%
Accumulated Other Comprehensive Income -250.4 -252.5 +0.8%
Treasury Stock Common Value -7,049.5 -6,089.7 -15.8%
Total Stockholders' Equity 10,205 — —
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 10,205 9,611.4 +6.2%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -3.9 -4 +2.5%
Accumulated Gain Loss Net Cash Flow Hedge Parent -23 -8.2 -180.5%
Accumulated Net Unrealized Investment Gain Loss -1.4 -5 +72.0%
Accumulated Other Comprehensive Income -250.4 -252.5 +0.8%
Accumulated Translation Adjustment -222.1 -235.3 +5.6%
Additional Paid In Capital 2,697.4 2,452.1 +10.0%
Common Stock 658.2 654.3 +0.6%
Parent 10,205 9,545.6 +6.9%
Retained Earnings 14,149.3 12,781.4 +10.7%
Treasury Stock Common -7,049.5 -6,089.7 -15.8%
Total Liabilities & Equity 13,272.2 12,971.2 +2.3%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q3 2025 YTD Q3 2024 YoY
Operating Activities
Depreciation & Amortization 113.9 112.6 +1.2%
Operating Lease Right Of Use Asset Amortization Expense 19.3 21.6 -10.6%
Stock-Based Compensation 118.9 130.6 -9.0%
Increase Decrease In Deferred Income Taxes -63.2 -224.9 +71.9%
Other Non-Cash Items 2.3 2.7 -14.8%
Increase Decrease In Accounts And Other Receivables -55.4 15.3 -462.1%
Change in Inventory 39.7 -204.9 +119.4%
Increase Decrease In Accounts Payable And Accrued Liabilities 226.4 92.6 +144.5%
Increase Decrease In Accrued Income Taxes Payable -199.4 301.8 -166.1%
Change in Prepaid & Other Assets -17.5 27.4 -163.9%
Increase Decrease In Legal Settlement Accrual -61.7 -24.3 -153.9%
Increase Decrease In Other Operating Capital Net -31.8 -4.1 -675.6%
Net Cash from Operations 1,144.3 669.8 +70.8%
Investing Activities
Capital Expenditures -162.8 -202.6 +19.6%
Payments To Acquire Interest In Subsidiaries And Affiliates -49.8 -32.9 -51.4%
Payments To Acquire Held To Maturity Securities -43.2 -36.3 -19.0%
Proceeds From Sale And Maturity Of Held To Maturity Securities 54.2 50.4 +7.5%
Purchases of Investments -2,265.2 -518.8 -336.6%
Proceeds From Sale And Maturity Of Available For Sale Securities 2,109.4 539.1 +291.3%
Disposal Group Payment For Working Capital Adjustment -36.3 3,927.4 -100.9%
Show Counterparty Name breakouts
Becton, Dickinson and Company · Critical Care -36.3 — —
Other Payments To Acquire Businesses -19.6 -16.2 -21.0%
Payments To Acquire Receivables -93.4 -28 -233.6%
Other Investing Activities -7.9 -3.5 -125.7%
Net Cash from Investing -514.6 2,889.6 -117.8%
Financing Activities
Share Repurchases -852.8 -1,059.3 +19.5%
Payments To Acquire Interest In Subsidiaries And Affiliates Financing Activities -233.7 — —
Proceeds From Stock Plans 141.8 150.9 -6.0%
Proceeds From Payments For Other Financing Activities -0.7 -3.2 +78.1%
Net Cash from Financing -945.4 -1,011.6 +6.5%
Supplemental
Unpaid Capital Expenditures 30.6 22.9 +33.6%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -48.3 -12.4 -289.5%
Net Change in Cash -364 2,535.4 -114.4%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2,694.8 3,683.4 -26.8%
Show Statement Operating Activities Segment breakouts
Segment Continuing Operations 2,687.3 3,680.5 -27.0%
Segment Discontinued Operations 7.5 2.9 +158.6%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key